Companies /Healthcare

Butterfly Network Inc - Class A

NYSE: BFLY Medical Devices
$5.71
▼ $0.37 (−6.09%) today
Markets closed · 1:08am ET

BFLY at a Glance

Valuation
Market cap
$1.6B
Profitability
Revenue (TTM)
$123.3M
Profit margin
-43.6%
EPS (TTM)
$-0.21
Price
52-week range
$2 – $10
Street target
$11.17

Headquartered in Burlington, MA Fiscal year ends December NYSE: BFLY butterflynetwork.com

About Butterfly Network

Butterfly Network, Inc. (NYSE: BFLY) develops ultrasound imaging and sensing technology built on its proprietary Ultrasound-on-Chip semiconductor platform, combined with cloud software and AI.

Point-of-care ultrasound: The company commercialized a single-probe, whole-body portable ultrasound device, now in its third generation as the Butterfly iQ3. It sells probes to health systems, distributors, eCommerce customers and global health partners.

Software: Butterfly sells software and services, including the Compass AI enterprise workflow solution, which landed multiple 6- and 7-figure TCV deals in Q3 2026. It also runs Butterfly Garden, a software development kit and AI marketplace for third-party imaging AI apps.

Butterfly Embedded: This is a licensing and co-development business that lets partners build ultrasound-enabled products on Butterfly's chip and software. Its reach is expanding into brain-computer interfaces (Merge Labs, Bridge Neurotech) and physical AI, alongside a co-development partnership with Midjourney. Mendaera launched the first commercial partner product in October 2026.

Other initiatives:
- Home & Community Care, with a first state program starting in Q4 2026.
- Medical education partnerships such as the Lighthouse program with VCOM.
- Federal sales supported by FedRAMP authorization.
- International expansion in Brazil and Taiwan.
- Next-generation chips (P5.1, Apollo) and wearable research devices.

In Q3 2026, software and other services revenue exceeded product revenue. Updated

BFLY Coverage

Frequently Asked Questions

What does Butterfly Network do?

Butterfly Network, Inc. (NYSE: BFLY) develops ultrasound imaging and sensing technology built on its proprietary Ultrasound-on-Chip semiconductor platform, combined with cloud software and AI.

What is the BFLY stock price target?

The Wall Street consensus 12-month price target for BFLY is $11.17.